Global Quinolones Market Segments 2024, Forecast To 2033
5 Mar, 2024
The quinolones market has witnessed steady growth, rising from $48.31 billion in 2023 to $50.65 billion in 2024, with a 4.9% CAGR. Drivers include antibiotic demand, regulatory approvals, and research and development. The forecast indicates steady growth, reaching $61.51 billion in 2028, with a 5.0% CAGR. Trends involve emerging diseases, regulatory changes, global health policies, antibiotic resistance, and market expansion strategies.
Global Quinolones Market Key Driver
The quinolones market is witnessing growth due to the increasing incidence of infectious diseases. Infectious diseases, such as tuberculosis, continue to pose global health challenges. The Pan American Health Organization reports a rise in tuberculosis cases, emphasizing the demand for effective treatments like quinolones. The market's expansion aligns with the persistent threat of infectious diseases worldwide.
Get A Free Sample Of The Global Quinolones Market ReportGlobal Quinolones Market Segments
The quinolones market covered in this report is segmented –
1) By Type: Norfloxacin, Ofloxacin, Ciprofloxacin, Gemifloxacin, Other Types
2) By Pathogen Type: Gram-Positive Pathogen, Gram-Negative Pathogen
3) By Application: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Geography: The regions covered in the anti inflammatory therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa. Among these regions.
North America was the largest region in the quinolones market in 2023. The regions covered in the quinolones market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Major Quinolones Industry Players
Bayer AG; Novartis AG; Sanofi SA; Johnson & Johnson Services Inc.; Merck & Co. Inc.; LG Life Sciences; Allergan Inc.; Pfizer Inc.; Viatris Inc.; Lupin Limited; Hikma Pharmaceuticals plc; Zydus Group; Bausch Health Companies Inc.; KYORIN Holdings Inc.; MerLion Pharmaceuticals GmbH; Teva Pharmaceutical Industries Ltd.; GSK plc; AbbVie Inc.; Zee Laboratories; Cipla Ltd.; Bhavishya Pharmaceuticals; Geo Pharma Pvt. Ltd.; Finecure Pharmaceuticals; Novus; AstraZeneca plc; Sun Pharmaceutical Industries Ltd.; Dr. Reddy's Laboratories Ltd.; Cadila Healthcare Ltd.; Glenmark Pharmaceuticals Ltd.; Alkem Laboratories Ltd.; Torrent Pharmaceuticals Ltd.; Macleods Pharmaceuticals Ltd.; Alembic Pharmaceuticals Ltd.; Hetero Drugs Ltd.; Mylan N.V.; Wockhardt Ltd.
Get The Full Global Quinolones Market Report
AIOps Quinolones Market Overview
Quinolones refer to bactericidal antibiotics that directly kill bacteria cells of both gram-positive and gram-negative types. Quinolones are used to treat various infectious diseases caused by bacteria.
Quinolones Global Market Report 2023 provides data on the global quinolones market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The quinolones market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.